Cervical dysplasia is the presence of abnormal cells in the cervix. Cases are classified as mild, moderate or severe depending on the extent of abnormal cell growth. Although the precise cause of ...

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)-- Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) biotechnology company, has dosed the first patient in its US Food and Drug ...

Only 45.5% of patients completed guideline-concordant surveillance within 30 months after treatment for high-grade cervical dysplasia, with one third of those receiving abnormal co-test results. Among ...

Please provide your email address to receive an email when new articles are posted on . Only 45.5% of women treated for high-grade cervical dysplasia completed two surveillance co-tests within 30 ...

Demonstrating a 40 percent response rate in high-grade cervical dysplasia patients, Stressgen Biotechnologies Corp.'s lead candidate, HspE7, appears to be heading toward another Phase III trial.

I had a Pap test recently, and my doctor said the results showed cervical dysplasia. What does that mean? Is it cancer? Answer From Shannon K. Laughlin-Tommaso, M.D. No. Cervical dysplasia isn't ...